Characterization of genetic diversity of the Klebsiella pneumoniae strains in a Moscow tertiary care center using next-generation sequencing | CMAC

Characterization of genetic diversity of the Klebsiella pneumoniae strains in a Moscow tertiary care center using next-generation sequencing

Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(1):69-74

​ Skachkova T.S., Shipulina O.Yu., Shipulin G.A., Shelenkov A.A., Yanushevich Yu.G., Mikhaylova Yu.V., Zamyatin M.N., Gusarov V.G., Petrova N.V., Lashenkova N.N., Fomina V.S., Shagin D.A.
10.36488/cmac.2019.1.69-74
Klebsiella pneumoniae antimicrobial resistance β-lactamase next-generation sequencing sequence type
Section
Personal Experience
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(1):69-74

Objective.

To study genetic diversity of Klebsiella pneumoniae strains obtained in the National Medical and Surgical Center named after N.I. Pirogov (Moscow) using next-generation sequencing.

Materials and Methods.

A total of 19 isolates of K. pneumoniae were included in the study (18 – from patients and 1 – from nosocomial environment). The strains were isolated from January 30 to October 9, 2017 and phenotypically showed multi-drug resistance. DNA sequencing of the strains was performed on the Illumina HiSeq1500 instrument using the Illumina HiSeq PE Rapid Cluster Kit v2 and Illumina HiSeq Rapid SBS Kit v2 kits.

Results.

A total of 9 different sequence types were found. One strain had a novel allelic profile. There was one hypervirulent strain of K. pneumoniae carrying a carbapenemase gene. The genes of beta-lactamase SHV were detected in each strain. The proportion of strains carrying CTX-M, OXA or TEM beta-lactamase genes was 63.2%, 68.4% and 57.9%, respectively. NDM-1 beta-lactamase genes were found in two strains. Nearly all strains had several types of beta-lactamase genes simultaneously. Plasmid-associated determinants of resistance to fluoroquinolones and the fosA gene providing resistance to fosfomycin were determined in 100% of strains.

Conclusions.

There was a high genetic diversity of K. pneumoniae strains isolated in the Moscow tertiary care center. No prevalence of any sequence type has been identified. Hypervirulent ST23 clones and high-risk resistant ST11 and ST147 clones were detected. Two hypervirulent strains ST23 had blaSHV-1, blaCTX-M-55, blaOXA-1 and blaSHV-1, blaOXA-48, respectively. The main mechanism of multiple antimicrobial resistance was β-lactamase production. Colistin was the only drug to which all K. pneumoniae strains were susceptible.

Tatyana S. Skachkova

Central Research Institute of Epidemiology, Moscow, Russia

Shipulina O.Yu.

Central Research Institute of Epidemiology, Moscow, Russia

Shipulin G.A.

Central Research Institute of Epidemiology, Moscow, Russia

Shelenkov A.A.

Central Research Institute of Epidemiology, Moscow, Russia

Yanushevich Yu.G.

Central Research Institute of Epidemiology, Moscow, Russia

Mikhaylova Yu.V.

Central Research Institute of Epidemiology, Moscow, Russia

Zamyatin M.N.

National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russia

Gusarov V.G.

National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russia

Petrova N.V.

National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russia

Lashenkova N.N.

National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russia

Fomina V.S.

National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russia

Shagin D.A.

Central Research Institute of Epidemiology, Moscow, Russia

  • 1. Sukhorukova M.V., Edelstein M.V., Skleenova E.Yu., et al. Antimicrobial resistance of nosocomial Enterobacteriaceae isolates in Russia: results of multicenter epidemiological study «MARATHON» 20132014. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2017;19(1):49-56.
  • 2. Boucher H.W., Talbot G.H., Bradley J.S., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1-12. DOI: 10.1086/595011
  • 3. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-155. DOI: 10.1378/chest.118.1.146
  • 4. Chang F.Y., Chou M.Y. Comparison of pyogenic liver abscesses caused by Klebsiella pneumoniae and non-K. pneumoniae pathogens. J Formos Med Assoc. 1995;94:232-237.
  • 5. Shon A.S., Bajwa R.P., Russo T.A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4(2):107-118. DOI: 10.4161/viru.22718
  • 6. Luo Y., Wang Y., Ye L., Yang J. Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect. 2014;20(11):818-824. DOI: 10.1111/1469-0691.12664
  • 7. Bialek-Davenet S., Criscuolo A., Ailloud F., et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis. 2014;20(11):1812-1820. DOI: 10.3201/eid2011.140206
  • 8. Yan J.J., Wang M.C., Zheng P.X., Tsai L.H., Wu J.J. Associations of the major international high-risk resistant clones and virulent clones with specific ompK36 allele groups in Klebsiella pneumoniae in Taiwan. New Microbes New Infect. 2015;5:1-4. DOI: 10.1016/j.nmni.2015.01.002
  • 9. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011;35:736-755. DOI: 10.1111/j.1574-6976.2011.00268.x
  • 10. Damjanova I., Tóth A., Pászti J., et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTXM-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 – the new ‘MRSAs’? J Antimicrob Chemother. 2008;62(5):978-985. DOI: 10.1093/jac/dkn287
  • 11. Samuelsen, Toleman M.A., Hasseltvedt V., et al. Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect. 2011;17(12):1811-1816. DOI: 10.1111/j.14690691.2011.03532.x
  • 12. Breurec S., Guessennd N., Timinouni M., et al. Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: multiclonal population structure with two major international clonal groups, CG15 and CG258. Clin Microbiol Infect. 2013; 19(4):349-355. DOI: 10.1111/j.14690691.2012.03805.x
  • 13. Lee M.Y., Ko K.S., Kang C.I., et al. High prevalence of CTX-M15-producing Klebsiella pneumonia isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents. 2011;38(2):160-163. DOI: 10.1016/j.ijantimicag.2011.03.020
  • 14. Chiu S.K., Wu T.L., Chuang Y.C., et al. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PLoS One. 2013;8(7):e69428. DOI: 10.1371/journal.pone.0069428
  • 15. Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66(2):307-312. DOI: 10.1093/jac/dkq431
  • 16. Ko K.S., Lee J.Y., Baek J.Y., et al. Predominance of an ST11 extended spectrum β-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J Med Microbiol. 2010;59:822-828. DOI: 10.1099/jmm.0.018119-0
  • 17. Illiaquer M., Caroff N., Bémer P., et al. Occurrence and molecular characterization of Klebsiella pneumoniae ST37 clinical isolates producing plasmid-mediated AmpC recovered over a 3-year period. Diagn Microbiol Infect Dis. 2012;74(1):95-97. DOI: 10.1016/j.diagmicrobio.2012.05.023
  • 18. Cejasa D., Canigiab L.F., Cruz G.R. First Isolate of KPC-2-Producing Klebsiella pneumonaie Sequence Type 23 from the Americas. J. Clin. Microbiol. 2014;52(9):3483-3485. DOI: 10.1128/JCM.00726-14
  • 19. Surgers L., Boyd A., Girard P.M., Arlet G., Decre D. ESBL-producing strain of hypervirulent Klebsiella pneumoniae K2, France. Emerg Infect Dis. 2016;22(9):1687-1688. DOI: 10.3201/eid2209.160681
  • 20. Diancourt L., Passet V., Verhoef J., Grimont P.A., Brisse S. Multilocus Sequence Typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43(8):4178-4182. DOI: 10.1128/JCM.43.8.4178-4182.2005
  • 21. Bialek-Davenet S., Criscuolo A., Ailloud F., et al. Genomic definition of Hypervirulent and Multidrug-Resistant Klebsiella pneumoniae Clonal Groups. Emerg Infect Dis. 2014;20(11):1812-20. DOI: 10.3201/eid2011.140206
  • 22. Larsen M.V., Cosentino S., Rasmussen S. Multilocus Sequence Typing of Total Genome Sequenced Bacteria. J Clin Micobiol. 2012;50(4):1355-1361. DOI: 10.1128/JCM.06094-11
  • 23. Zankari E., Hasman H., Cosentino S., et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640-2644. DOI: 10.1093/jac/dks261
  • 24. Carattoli A., Zankari E., Garcia-Fernandez A., et al. PlasmidFinder and pMLST: in silico detection and typing of plasmids. Antimicrob Agents Chemother. 2014;58(7):3895-903. DOI: 10.1128/AAC.02412-14
  • 25. Page A.J., Cummins C.A., Hunt M., et al. Roary: Rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):36913693. DOI: 10.1093/bioinformatics/btv421
  • 26. Stöver B.C., Müller K.F. TreeGraph 2: Combining and visualizing evidence from different phylogenetic analyses. BMC Bioinformatics. 2010;11:7. DOI: 10.1186/1471-2105-11-7
  • 27. Hennequin C., Robin F. Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis. 2016;35(3):333-341. DOI: 10.1007/s10096-015-2559-7
  • 28. Stratchounski L.S. Extended-Spectrum β-Lactamases – Rapidly spreading and underestimated problem. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2005;7(1):92-96.
  • 29. Tapalski D.V., Osipov V.A., Zhavoronok S.V. Сarbapenemases of gramnegative pathogens: spread and methods of detection. Medicinskij zhurnal. 2012;2(40):1015.
  • 30. Carmeli Y., Armstrong J., Laud P.J., et al. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. Lancet Infect Dis. 2016;16(6):661-673. DOI: 10.1016/S1473-3099(16)30004-4
  • 31. Papp-Wallace K.M., Bonomo R.A. New β-Lactamase Inhibitors in the Clinic. Infect Dis Clin North Am. 2016;30(2):441-464. DOI: 10.1016/j.idc.2016.02.007
  • 32. Yong D., Toleman M.A., Christian G.G., et al. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046-5054. DOI: 10.1128/AAC.00774-09
  • 33. Kumarasamy K.K., Toleman M.A., Walsh T.R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597-602. DOI: 10.1016/S1473-3099(10)70143-2
  • 34. Ageevets V.A., Partina I.V., Lisitsyina E.S., et al. The first detection of metallo-beta-lactamase NDM-type multidisciplinary hospital in Russia. Meditsinskiy akademicheskiy zhurnal. 2012;(4):43-45.
  • 35. Shabanova V.V., Krasnova M.V., Bozhkova S.A., et al. The first case of isolation of Klebsiella pneumoniae ST147, producing NDM-1 carbapenemase, in trauma and orthopedic hospital in Russia. Travmatologija i ortopedija Rossii. 2015;(2):90-98. Russian.
  • 36. Robicsek A., Jacoby G.A., Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006;6(10):629-640. DOI: 10.1016/S1473-3099(06)70599-0
  • 37. Jacoby G.A. Plasmid-Mediated Quinolone Resistance. In: Mayers D., Sobel J., Ouellette M., Kaye K., Marchaim D., Eds. Antimicrobial Drug Resistance. Springer, Cham. 2017. 265-268 pp. DOI: 10.1007/9783-319-46718-4
  • 38. Kozlov S.N., Stratchounski L.S. Modern Antimicrobial Chemotherapy: A Guide for Physicians. M., 2009.
  • 39. Castaneda-Garcia A., Blazquez J., Rodrıguez-Rojas A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics. 2013;2(2):217-236. DOI: 10.3390/antibiotics2020217
  • 40. Silver L.L. Fosfomycin: Mechanism and Resistance. Cold Spring Harb Perspect Med. 2017;7(2):a025262. DOI: 10.1101/cshperspect.a025262
  • 41. Marchaim D., Chopra T., Jason M.P., et al. Outbreak of ColistinResistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan Antimicrob Agents Chemother. 2011;55:593-599. DOI: 10.1128/AAC.01020-10
  • 42. Antoniadou A., Kontopidou F., Poulakou G., et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother. 2007;59(4):786-790. DOI: 10.1093/jac/dkl562
  • 43. Capone A., Giannella M., Fortini D., et al. High rate of colistin resistance among patients with carbapenem‐resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013;19(1):E23-E30. DOI: 10.1111/1469-0691.12070
Views
0 Abstract
0 PDF
0 Crossref citations
Shared